WallStreetZenWallStreetZen

NASDAQ: CSTL
Castle Biosciences Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Castle Biosciences revenue was $311.88M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $85.8M, down 1.4% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, CSTL annual revenue was $219.8M, with 60.4% growth year-over-year.

CSTL past revenue growth

How has CSTL's revenue growth performed historically?

Company
62.43%
Industry
1.05%
Market
34.78%
CSTL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CSTL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CSTL's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CSTL revenue history

Current Revenue
$311.9M
Current Earnings
$6.1M
Current Profit Margin
1.9%

Be the first to know when CSTL announces revenue.

CSTL Revenue History By Year

CSTL Yearly RevenueCSTL RevenueCSTL ChangeCSTL Revenue Growth
2023-12-31$219.79M$82.75M+60.38%
2022-12-31$137.04M$42.95M+45.65%
2021-12-31$94.09M$31.44M+50.18%
2020-12-31$62.65M$10.78M+20.79%
2019-12-31$51.87M$29.08M+127.62%
2018-12-31$22.79M$9.03M+65.67%
2017-12-31$13.75MN/AN/A

1 of 1

Castle Biosciences Revenue FAQ

What was CSTL's revenue last quarter?

On Invalid Date, Castle Biosciences (NASDAQ: CSTL) reported Q3 2024 revenue of $85.78 million up 39.5% year over year. In the same quarter last year, Castle Biosciences's revenue was $61.49 million.

What was Castle Biosciences's revenue in 2023?

Castle Biosciences's annual revenue for the twelve months ending Dec 31, 2023 was $219.79 million, a 60.38% increase year over year.

How much does Castle Biosciences make in a day?

Based on Castle Biosciences annual revenue for the past five years, CSTL makes an average of $309,822.47 per day.

What was Castle Biosciences's annual revenue growth in the past year?

As of Q1 2025, Castle Biosciences's revenue has grown 62.43% year over year. This is 61.39 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 1.05%. Castle Biosciences's revenue in the past year totaled $311.88 million.

How much does Castle Biosciences make in a year?

Castle Biosciences's revenue by year for the past five years is:
  • Castle Biosciences's revenue for the twelve months ending Dec 31, 2023 was $219.79 million, a 60.38% increase year over year.
  • Castle Biosciences's annual revenue for Dec 31, 2022 was $137.04 million, a 45.65% increase from 2021.
  • Castle Biosciences's annual revenue for 2021 was $94.09 million, a 50.18% increase from 2020.
  • Castle Biosciences's annual revenue for 2020 was $62.65 million, a 20.79% increase from 2019.
  • Castle Biosciences's annual revenue for 2019 was $51.87 million, a 127.62% increase from 2018.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.